TE-15Homo sapiens (Human)Cancer cell line
Also known as: Te15, TE15
Quick Overview
Human esophageal squamous cell carcinoma cell line
Detailed Summary
Research Applications
Key Characteristics
Basic Information
Database ID | CVCL_1763 |
---|---|
Species | Homo sapiens (Human) |
Tissue Source | Esophagus[UBERON:UBERON_0001043] |
Donor Information
Age | 58 |
---|---|
Age Category | Adult |
Sex | Female |
Disease Information
Disease | Squamous cell carcinoma of the esophagus |
---|---|
Lineage | Esophagus/Stomach |
Subtype | Esophageal Squamous Cell Carcinoma |
OncoTree Code | ESCC |
DepMap Information
Source Type | RIKEN |
---|---|
Source ID | ACH-000353_source |
Known Sequence Variations
Type | Gene/Protein | Description | Zygosity | Note | Source |
---|---|---|---|---|---|
MutationSimple | TP53 | c.560-1G>A | Unspecified | Splice acceptor mutation | PubMed=9096669 |
Haplotype Information (STR Profile)
Short Tandem Repeat (STR) profile for cell line authentication.
Loading gene expression data...
Publications
Pan-cancer proteomic map of 949 human cell lines.";
Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.
Cancer Cell 40:835-849.e8(2022).
Next-generation characterization of the Cancer Cell Line Encyclopedia.
Sellers W.R.
Nature 569:503-508(2019).
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.
Stronach E.A., Saez-Rodriguez J., Yusa K., Garnett M.J.
Nature 568:511-516(2019).
An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.
Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.
Cancer Res. 79:1263-1273(2019).
A landscape of pharmacogenomic interactions in cancer.";
Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
Cell 166:740-754(2016).
Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies.
Golub T.R., Root D.E., Hahn W.C.
Sci. Data 1:140035-140035(2014).
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.
Nature 483:603-607(2012).
Signatures of mutation and selection in the cancer genome.";
Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.
Nature 463:893-898(2010).
Mistaken identity of widely used esophageal adenocarcinoma cell line TE-7.
Lowe A.W., Beverloo H.B., van Dekken H., Tilanus H.W., Dinjens W.N.M.
Cancer Res. 67:7996-8001(2007).
Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma.
Imamura M., Amagasa T., Gray J.W., Hirohashi S., Inazawa J.
Cancer Res. 64:3741-3747(2004).
Screening the p53 status of human cell lines using a yeast functional assay.
Mizusawa H., Tanaka N., Koyama H., Namba M., Kanamaru R., Kuroki T.
Mol. Carcinog. 19:243-253(1997).
Inactivation of the p53 protein in cell lines derived from human esophageal cancers.
Hainaut P.
Int. J. Cancer 71:79-87(1997).